Filter
550
Filtered Results: 550
Text search:
European
Medicines
Agency
EMA
Featured
Recommendations
64
New Publications
122
Language
Document type
No document type
265
Studies & Reports
112
Guidelines
91
Manuals
31
Fact sheets
23
Strategic & Response Plan
13
Situation Updates
5
Training Material
4
Brochures
2
Resource Platforms
2
Infographics
1
Online Courses
1
Countries / Regions
Western and Central Europe
29
Ukraine
13
Kenya
11
Eastern Europe
11
Germany
10
Nigeria
9
Sierra Leone
8
Global
8
Ethiopia
8
Liberia
8
Myanmar / Burma
8
Ghana
7
Africa
7
Zambia
7
Tanzania
6
South Africa
6
Syria
5
Uganda
5
India
5
Nepal
4
Guinea
4
Eastern Europe and Central Asia
4
Brazil
4
Indonesia
4
Tajikistan
3
Albania
3
Malawi
3
Zimbabwe
3
Philippines
3
Venezuela
3
Congo, Democratic Republic of
3
West and Central Africa
3
East and Southern Africa
3
Bangladesh
3
Namibia
3
Yemen
3
Colombia
2
Serbia
2
Lesotho
2
Rwanda
2
Estonia
2
Cambodia
2
Latin America and the Carribbean
2
Jordan
2
Moldova
2
Russia
2
Georgia
2
South Sudan
2
Eswatini/ Swaziland
2
North Macedonia
1
Thailand
1
El Salvador
1
China
1
Kazakhstan
1
Chile
1
Cameroon
1
Iran
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Peru
1
Morocco
1
Mongolia
1
Armenia
1
USA
1
Haiti
1
Saudi Arabia
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Egypt
1
Sudan
1
Greece
1
Libya
1
Botswana
1
Iraq
1
Somalia
1
Ecuador
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
132
Clinical Guidelines
70
Women & Child Health
34
Key Resources
31
Public Health
29
Pharmacy & Technologies
12
Capacity Building
5
Toolboxes
COVID-19
61
AMR
48
HIV
42
Mental Health
41
TB
38
Rapid Response
33
Planetary Health
23
Pharmacy
22
Ebola & Marburg
21
Disability
17
Refugee
16
Conflict
15
NTDs
13
Global Health Education
12
Caregiver
10
Specific Hazards
8
Zika
7
NCDs
3
Natural Hazards
2
Cholera
2
Polio
2
Social Ethics
1
Supplement to: Guidance on vaccination and prevention of vaccine-preventable disease outbreaks for countries hosting refugees from Ukraine, April 2022 update
This document provides: • information on how to obtain vaccination documentation remotely (intended for refugees from Ukraine and intern...
What at first glance appears to be simple causality – climate change leading to more and more migration – has triggered intense academic debate over the past ten years because the circumstances are complex. There is need for a thorough analysis in the ground between denying the problem and asser...
Consensual recommendations for outpatient management and home care
and home treatment of patients with COVID-19
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children who are in contact with infectious TB cases (through implementation of active contact investigation and provision of preventive treatment); an...
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...
The End TB Strategie
The Lancet Infectious Disease Volume 25, Issue 2e77-e85February 2025
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
In Control: A Practical Handbook for Professionals Working in Health Emergencies Internationally RKI
The greatest risk to persons engaging in international medical emergency response is poor preparation.
The In Control handbook hopes to provide a remedy.
At the time of writing, we are living through the Coronavirus (COVID-19) pandemic, a health emergency that disregards physical borders, brin...
In Control. A Practical Handbook for Professionals Working in Health Emergencies Internationally
recommended
In Control imparts knowledge, provokes reflection and triggers curiosity. The first half of the book provides an overview of the organisations, principles, frameworks and themes that every professional deploying to health emergencies should be aware of. The second half of the book provides practical...
This paper focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment. It presents concrete examples of the underlying and complex aspects of antibiotic resistance and its impacts across different Sustainable Development ...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
ESTA NOTA INFORMATIVA SUBSTITUI A NOTA INFORMATIVA Nº 11/2020-SE/GAB/SE/MS, DE 15 DE JUNHO DE 2020, QUE SUBSTITUIU A NOTA INFORMATIVANº 9/2020-SE/GAB/SE/MS, DE 20 DE MAIO DE 2020
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
An Act to provide for the efficient and comprehensive regulation and control of food, drugs, medical devices, cosmetics, herbal drugs and poisons and to repeal the Food
(Control of Quality) Act, 1978, the Pharmaceuticals and Poisons Act, 1978 and to provide for related matters.
